For instance, when ECs undergo chemotherapy, insulin-like growth factor binding protein-7 (IGFBP7/angiomodulin) expression is suppressed, resulting in the emergence of chemoresistant and aggressive tumor cells, which potentially contribute to tumor progression and metastasis [64]. Here, IGFBP7 is linked to neoplasm.